Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Brazil extends R$640m A&E modernisation

This article was originally published in Clinica

Executive Summary

Authorities from Palmas, the capital of Brazil's Tocantins state, have begun negotiations with the federal health ministry on how they will spend their share of a R$640m (US$266m) investment in A&E service modernisation in 2005-06, mainly for equipment. Tocantins thus becomes the tenth of Brazil's 27 states to be involved in the QualiSUS programme to improve A&E facilities and meet stringent new standards of care. It has so far been implemented in five state capitals - Porto Alegre, Recife, Rio de Janeiro, Fortaleza and Aracaju - and is currently being set up in a further four: Belo Horizonte, Goiania, Natal and Curitiba. By the end of this year, the health ministry aims to cover the main A&E specialties in all 27 states (including the Federal District). QualiSUS stands for Qualificacao da Atencao a Saude no SUS (Sistema Unico di Saude).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT055292

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel